Professor
Cleveland Clinic Foundation
Chagrin Falls, OH, United States
Joseph Scharpf, MD, FACS, is a Professor of Otolaryngology- Head & Neck Surgery in the Cleveland Clinic Lerner College of Medicine and a Member of the Cleveland Clinic’s Head and Neck Institute in the Head and Neck Surgery section. Dr. Scharpf serves as the Vice Chair for Professional Development and Continuing Education for HNI He is board-certified in Otolaryngology, Head and Neck Surgery. His specialty interests include thyroid and parathyroid surgery, head and neck cancer, benign head and neck tumors including salivary tumors and paragangliomas, and skull base surgery. He serves as the Director of Head and Neck Endocrine Surgery at The Cleveland Clinic.
Dr. Scharpf’s education includes a Bachelor of Arts, Summa Cum Laude, from Case Western Reserve University and a Medical Doctorate from the Ohio State University College of Medicine and Public Health, where he was inducted into the Alpha Omega Alpha Honor Society. He completed a general surgery internship and an otolaryngology, head and neck surgery residency including an additional year of research at the Cleveland Clinic. He pursued further fellowship training in advanced head and neck cancer, endocrine, and reconstructive surgery at the University of Iowa in Iowa City, IA before returning to the Cleveland Clinic.
He has published a book on Intraoperative Nerve Monitoring in Head & Neck Surgery, numerous peer-reviewed journal articles and multiple book chapters on head and neck cancer and reconstruction, and has delivered numerous presentations both nationally and internationally. Dr. Scharpf also serves as an educator, teaching medical students, residents, and fellows. He is a reviewer for several major scientific journals in his field and has served as a consultant for ThyCa, an organization dedicated to the well-being of those afflicted with thyroid cancer.
Sunday, September 29, 2024
8:00 AM – 9:00 AM EDT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
Evidence-Based Management of Invasive Thyroid Cancer
Sunday, September 29, 2024
9:30 AM – 10:30 AM EDT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
AAO-HNS Thyroid Cancer Tumor Board
Monday, September 30, 2024
2:30 PM – 3:30 PM EDT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.